Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07668635 · ClinicalTrials.gov registry record · Phase 1
Cannabis Effects on Opioid Self-Administration
A Phase 1 study, sponsored by Shanna Babalonis, PhD.
- Not yet
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT07668635 is a Phase 1 study that has not yet begun recruiting, run by Shanna Babalonis, PhD. The registered enrollment target is 30 participants.
The verdict
NCT07668635, a Phase 1 study, has not yet begun recruiting, sponsored by Shanna Babalonis, PhD.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
The study will enroll participants with opioid use disorder and participants will reside at the University of Kentucky Hospital for this 6-week inpatient trial. During this time, double-blind doses of cannabis and opioids will be administered. The goal of the project is to determine if cannabis can alter the drive/desire to take opioids.
Interventions
- DRUG Cannabis
- DRUG Placebo Cannabis
- DRUG Intranasal Opioid Agonist
- DRUG Oral Opioid Agonist
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-07-30 |
| Est. Completion | 2031-07-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07668635
The ClinicalTrials.gov registry entry for NCT07668635 describes a study currently listed as not yet recruiting, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shanna Babalonis, PhD, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Cannabis is the first listed.
NCT07668635 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07668635 about?
NCT07668635 is a clinical study titled "Cannabis Effects on Opioid Self-Administration". The study will enroll participants with opioid use disorder and participants will reside at the University of Kentucky Hospital for this 6-week inpatient trial. During this time, double-blind doses of cannabis and opioids will be administered. The goal of the project is to determine if cannabis can ...
What is the current status of trial NCT07668635?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2026-07-30. Estimated completion is 2031-07-30.
What interventions are being tested in trial NCT07668635?
The interventions under investigation include: Cannabis (DRUG), Placebo Cannabis (DRUG), Intranasal Opioid Agonist (DRUG), Oral Opioid Agonist (DRUG).
Who is sponsoring clinical trial NCT07668635?
This trial is sponsored by Shanna Babalonis, PhD, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.